Hidradenitis suppurativa
☆ A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
Hidradenitis suppurativa (mataki na I) a cikin hammata. Wannan lamari ne mai sauƙi na Hidradenitis suppurativa.
References
Hidradenitis suppurativa cuta ce ta fata da ke daɗe da dawowa, kuma tana iya shafar rayuwar ku sosai. Yana haifar da kumburi a cikin ɓawon gashi, kuma sau da yawa yana haifar da cututtukan ƙwayoyin cuta. Likitoci kan tantance shi ta hanyar duba nau’in ciwon da kake da shi (kamar nodules, abscesses, ko sinus tracts) , inda suke (yawanci a cikin folds na fata) , da sau nawa suke dawowa da kuma tsawon lokacin da suke tsayawa.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Magungunan da ba na ilimin halitta da waɗanda ba na tsari ba ana amfani da su kaɗai don ƙarancin cuta kuma ana iya haɗa su tare da ilimin ilimin halitta da tiyata don matsakaici zuwa matsananciyar cuta. Binciken da aka yi kwanan nan ya ba da ƙarin shaida na tasiri don amfani da corticosteroids da aka allura kai tsaye a cikin raunuka don HS flare-ups da ƙananan raunuka. Bugu da ƙari, akwai shaidun da ke nuna cewa yin amfani da tetracyclines kadai na iya zama tasiri kamar hada clindamycin da rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Ana amfani da jiyya da yawa don hidradenitis suppurativa, ciki har da maganin rigakafi, retinoids, antiandrogens, magungunan da ke hana rigakafi, magungunan ƙwayoyin cuta, da kuma maganin rediyo don raunuka na farko. Babban shawarwarin jiyya sune adalimumab da lasertherapy. Tiyata, ko dai fiɗa mai sauƙi ko cikakken fiddawar gida tare da dasa fata, shine zaɓin da aka fi so don matsananci, manyan lokuta waɗanda ba su da kyau ga sauran jiyya.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Ba a san ainihin dalilin da ya sa galibi ba, amma an yi imanin cewa ya ƙunshi haɗaɗɗun abubuwan halitta da muhalli. Kusan kashi ɗaya bisa uku na mutanen da ke fama da cutar suna da ɗan dangi da ya shafa. Sauran abubuwan haɗari sun haɗa da kiba da shan taba. Yanayin ba ya haifar da kamuwa da cuta, rashin tsabta.
Ba a san magani ba. Yanke raunuka don ba da damar su zubar ba ya haifar da fa'ida mai mahimmanci. Yayin da ake yawan amfani da maganin rigakafi, shaidar amfani da su ba ta da kyau. Hakanan ana iya gwada magungunan rigakafin rigakafi. A cikin waɗanda ke da cututtuka masu tsanani, maganin laser ko tiyata don cire fata da aka shafa na iya yiwuwa. Da wuya, raunin fata na iya haɓaka zuwa kansar fata.
Idan an haɗa ƙananan lokuta na hidradenitis suppurativa , to, ƙididdiga ta mita daga 1-4% na yawan jama'a. Mata sun fi maza samun kamuwa da ita sau uku. Farawa yawanci yana cikin ƙuruciya.